C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

By: Investing.com

Oct 30 2024
72
8191 Views

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

WATERTOWN, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science,… [+1958 chars]

The Third Atomic Bomb: Self-replicating RNA vaccines

Forgotten Antibiotic From Decades Past Could Be a Superbug Killer

'Frightening': Over 1 in 3 of world's tree species face extinction

Third US State May Legalize Psychedelics

Nature Protection in 2045 - The Impending Necessity of Nature Funding

Antibacterial effects of Kampo products against pneumonia causative bacteria

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Nantahala Capital Management LLC Acquires 1,634,046 Shares of Nektar Therapeutics (NASDAQ:NKTR)

Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT

Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care

Psyence Biomedical Ltd. (NASDAQ:PBM) Short Interest Up 181.5% in October

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Related